2022-04-012023-03-312023-03-31false07189863Mesmermorphosis Ltd2023-11-16iso4217:GBPxbrli:pure071898632022-04-01071898632023-03-31071898632022-04-012023-03-31071898632021-04-01071898632022-03-31071898632021-04-012022-03-3107189863bus:SmallEntities2022-04-012023-03-3107189863bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3107189863bus:FullAccounts2022-04-012023-03-3107189863bus:PrivateLimitedCompanyLtd2022-04-012023-03-3107189863core:WithinOneYear2023-03-3107189863core:AfterOneYear2023-03-3107189863core:WithinOneYear2022-03-3107189863core:AfterOneYear2022-03-3107189863core:ShareCapital2023-03-3107189863core:SharePremium2023-03-3107189863core:RevaluationReserve2023-03-3107189863core:OtherReservesSubtotal2023-03-3107189863core:RetainedEarningsAccumulatedLosses2023-03-3107189863core:ShareCapital2022-03-3107189863core:SharePremium2022-03-3107189863core:RevaluationReserve2022-03-3107189863core:OtherReservesSubtotal2022-03-3107189863core:RetainedEarningsAccumulatedLosses2022-03-3107189863core:LandBuildings2023-03-3107189863core:PlantMachinery2023-03-3107189863core:Vehicles2023-03-3107189863core:FurnitureFittings2023-03-3107189863core:OfficeEquipment2023-03-3107189863core:NetGoodwill2023-03-3107189863core:IntangibleAssetsOtherThanGoodwill2023-03-3107189863core:ListedExchangeTraded2023-03-3107189863core:UnlistedNon-exchangeTraded2023-03-3107189863core:LandBuildings2022-03-3107189863core:PlantMachinery2022-03-3107189863core:Vehicles2022-03-3107189863core:FurnitureFittings2022-03-3107189863core:OfficeEquipment2022-03-3107189863core:NetGoodwill2022-03-3107189863core:IntangibleAssetsOtherThanGoodwill2022-03-3107189863core:ListedExchangeTraded2022-03-3107189863core:UnlistedNon-exchangeTraded2022-03-3107189863core:LandBuildings2022-04-012023-03-3107189863core:PlantMachinery2022-04-012023-03-3107189863core:Vehicles2022-04-012023-03-3107189863core:FurnitureFittings2022-04-012023-03-3107189863core:OfficeEquipment2022-04-012023-03-3107189863core:NetGoodwill2022-04-012023-03-3107189863core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107189863core:ListedExchangeTraded2022-04-012023-03-3107189863core:UnlistedNon-exchangeTraded2022-04-012023-03-3107189863core:MoreThanFiveYears2022-04-012023-03-3107189863core:Non-currentFinancialInstruments2023-03-3107189863core:Non-currentFinancialInstruments2022-03-3107189863dpl:CostSales2022-04-012023-03-3107189863dpl:DistributionCosts2022-04-012023-03-3107189863core:LandBuildings2022-04-012023-03-3107189863core:PlantMachinery2022-04-012023-03-3107189863core:Vehicles2022-04-012023-03-3107189863core:FurnitureFittings2022-04-012023-03-3107189863core:OfficeEquipment2022-04-012023-03-3107189863dpl:AdministrativeExpenses2022-04-012023-03-3107189863core:NetGoodwill2022-04-012023-03-3107189863core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107189863dpl:GroupUndertakings2022-04-012023-03-3107189863dpl:ParticipatingInterests2022-04-012023-03-3107189863dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107189863core:ListedExchangeTraded2022-04-012023-03-3107189863dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107189863core:UnlistedNon-exchangeTraded2022-04-012023-03-3107189863dpl:CostSales2021-04-012022-03-3107189863dpl:DistributionCosts2021-04-012022-03-3107189863core:LandBuildings2021-04-012022-03-3107189863core:PlantMachinery2021-04-012022-03-3107189863core:Vehicles2021-04-012022-03-3107189863core:FurnitureFittings2021-04-012022-03-3107189863core:OfficeEquipment2021-04-012022-03-3107189863dpl:AdministrativeExpenses2021-04-012022-03-3107189863core:NetGoodwill2021-04-012022-03-3107189863core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3107189863dpl:GroupUndertakings2021-04-012022-03-3107189863dpl:ParticipatingInterests2021-04-012022-03-3107189863dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3107189863core:ListedExchangeTraded2021-04-012022-03-3107189863dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3107189863core:UnlistedNon-exchangeTraded2021-04-012022-03-3107189863core:NetGoodwill2023-03-3107189863core:IntangibleAssetsOtherThanGoodwill2023-03-3107189863core:LandBuildings2023-03-3107189863core:PlantMachinery2023-03-3107189863core:Vehicles2023-03-3107189863core:FurnitureFittings2023-03-3107189863core:OfficeEquipment2023-03-3107189863core:AfterOneYear2023-03-3107189863core:WithinOneYear2023-03-3107189863core:ListedExchangeTraded2023-03-3107189863core:UnlistedNon-exchangeTraded2023-03-3107189863core:ShareCapital2023-03-3107189863core:SharePremium2023-03-3107189863core:RevaluationReserve2023-03-3107189863core:OtherReservesSubtotal2023-03-3107189863core:RetainedEarningsAccumulatedLosses2023-03-3107189863core:NetGoodwill2022-03-3107189863core:IntangibleAssetsOtherThanGoodwill2022-03-3107189863core:LandBuildings2022-03-3107189863core:PlantMachinery2022-03-3107189863core:Vehicles2022-03-3107189863core:FurnitureFittings2022-03-3107189863core:OfficeEquipment2022-03-3107189863core:AfterOneYear2022-03-3107189863core:WithinOneYear2022-03-3107189863core:ListedExchangeTraded2022-03-3107189863core:UnlistedNon-exchangeTraded2022-03-3107189863core:ShareCapital2022-03-3107189863core:SharePremium2022-03-3107189863core:RevaluationReserve2022-03-3107189863core:OtherReservesSubtotal2022-03-3107189863core:RetainedEarningsAccumulatedLosses2022-03-3107189863core:NetGoodwill2021-04-0107189863core:IntangibleAssetsOtherThanGoodwill2021-04-0107189863core:LandBuildings2021-04-0107189863core:PlantMachinery2021-04-0107189863core:Vehicles2021-04-0107189863core:FurnitureFittings2021-04-0107189863core:OfficeEquipment2021-04-0107189863core:AfterOneYear2021-04-0107189863core:WithinOneYear2021-04-0107189863core:ListedExchangeTraded2021-04-0107189863core:UnlistedNon-exchangeTraded2021-04-0107189863core:ShareCapital2021-04-0107189863core:SharePremium2021-04-0107189863core:RevaluationReserve2021-04-0107189863core:OtherReservesSubtotal2021-04-0107189863core:RetainedEarningsAccumulatedLosses2021-04-0107189863core:AfterOneYear2022-04-012023-03-3107189863core:WithinOneYear2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107189863core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107189863core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107189863core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3107189863core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3107189863core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3107189863bus:Director12022-04-012023-03-3107189863bus:Director22022-04-012023-03-31

Mesmermorphosis Ltd

Registered Number
07189863
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

Mesmermorphosis Ltd
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

Ms J Lomax
Mr B Quinn

Registered Address

The Flat Wauldby Manor
Wauldby Road
Welton
HU15 1QR

Registered Number

07189863 (England and Wales)
Mesmermorphosis Ltd
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets711
11
Current assets
Cash at bank and on hand2020
2020
Creditors amounts falling due within one year9(15,549)(13,332)
Net current assets (liabilities)(15,529)(13,312)
Total assets less current liabilities(15,528)(13,311)
Net assets(15,528)(13,311)
Capital and reserves
Called up share capital100100
Profit and loss account(15,628)(13,411)
Shareholders' funds(15,528)(13,311)
The financial statements were approved and authorised for issue by the Board of Directors on 16 November 2023, and are signed on its behalf by:
Ms J Lomax
Director
Registered Company No. 07189863
Mesmermorphosis Ltd
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company is consultancy and hypnotherapy
4.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Government grants and other government assistance policy
Grants relating to revenue are recognised in the profit and loss on a systematic basis over the periods in which the entity recognises the related costs for which the grant is intended to compensate.
Going concern
Whilst the company has net liabilities, the directors believe that it is appropriate for the accounts to be prepared on a going concern basis as the shareholder has indicated that they will provide such support as necessary in order to ensure the company can trade for the foreseeable future. Without such support the ability of the company to trade successfully throughout the next 12 months may be in doubt.
6.Employee information

20232022
Average number of employees during the year11
7.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
At 01 April 22472472
At 31 March 23472472
Depreciation and impairment
At 01 April 22471471
At 31 March 23471471
Net book value
At 31 March 2311
At 31 March 2211
8.Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts.
9.Creditors within one year

2023

2022

££
Amounts owed to related parties15,02612,852
Accrued liabilities and deferred income523480
Total15,54913,332
Short term creditors are measured at transaction price (which is usually the invoice price).